We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Bioceres Crop Solutions
BIOX
$24.6M
| – | – |
0
| – | – |
|
1402
Ziff Davis
ZD
$2.01B
| $349K | ﹤0.01% |
5,530
-306
| -5% | -$20.3K |
|
1403
Las Vegas Sands
LVS
$26.6B
| $349K | ﹤0.01% |
6,742
+2,542
| +61% | +$131K |
|
1404
Federated Hermes
FHI
$4.23B
| $344K | ﹤0.01% |
9,524
-1,324
| -12% | -$46.5K |
|
1405
Marathon Digital Holdings
MARA
$4.26B
| $342K | ﹤0.01% |
+15,135
| New | +$331K |
|
1406
OraSure Technologies
OSUR
$240M
| $341K | ﹤0.01% |
55,505
+1,165
| +2% | +$8.46K |
|
1407
Assembly Biosciences
ASMB
$519M
| $338K | ﹤0.01% |
25,394
-1
| -0% | -$12 |
|
1408
General Dynamics
GD
$97.4B
| $335K | ﹤0.01% |
1,185
+447
| +61% | +$120K |
|
1409
Fluence Energy
FLNC
$1.3B
| $333K | ﹤0.01% |
19,218
+1,996
| +12% | +$36.5K |
|
|
CWEN.A
1410
DELISTED
Clearway Energy Class A
CWEN.A
| $332K | ﹤0.01% |
15,420
-348
| -2% | -$7.62K |
|
1411
Phinia Inc
PHIN
$2.24B
| $329K | ﹤0.01% |
8,552
-2,674
| -24% | -$87K |
|
|
PBPB
1412
DELISTED
Potbelly
PBPB
| $329K | ﹤0.01% |
27,134
+26,656
| +5,577% | +$334K |
|
1413
Pitney Bowes
PBI
$2.37B
| $322K | ﹤0.01% |
74,347
+5,672
| +8% | +$23.4K |
|
1414
TriNet
TNET
$3.18B
| $319K | ﹤0.01% |
2,409
-116
| -5% | -$14.1K |
|
1415
Amphenol
APH
$191B
| $315K | ﹤0.01% |
10,908
-372
| -3% | -$9.75K |
|
1416
Insperity
NSP
$1.97B
| $314K | ﹤0.01% |
2,866
-1,548
| -35% | -$165K |
|
1417
Ingles Markets
IMKTA
$1.57B
| $312K | ﹤0.01% |
4,069
-1,641
| -29% | -$131K |
|
|
LEG
1418
DELISTED
Leggett & Platt
LEG
| $312K | ﹤0.01% |
16,291
-430
| -3% | -$9.35K |
|
1419
Expensify
EXFY
$210M
| $309K | ﹤0.01% |
168,073
+6,927
| +4% | +$13.1K |
|
1420
Exponent
EXPO
$3.23B
| $309K | ﹤0.01% |
3,731
-481
| -11% | -$39.8K |
|
1421
First Financial Bankshares
FFIN
$4.78B
| $308K | ﹤0.01% |
9,394
-851
| -8% | -$26.1K |
|
1422
Fox Class A
FOXA
$27.8B
| $306K | ﹤0.01% |
9,779
-966
| -9% | -$29.3K |
|
|
AMED
1423
DELISTED
Amedisys
AMED
| $304K | ﹤0.01% |
3,294
-224
| -6% | -$21K |
|
|
PRA
1424
DELISTED
ProAssurance
PRA
| $303K | ﹤0.01% |
23,536
-8,454
| -26% | -$109K |
|
1425
International Bancshares
IBOC
$4.41B
| $300K | ﹤0.01% |
5,350
-345
| -6% | -$18.3K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.